These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32210578)

  • 1. Simultaneous Overexpression of miR-126 and miR-34a Induces a Superior Antitumor Efficacy in Pancreatic Adenocarcinoma [Retraction].
    Onco Targets Ther; 2020; 13():2125. PubMed ID: 32210578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma.
    Feng SD; Mao Z; Liu C; Nie YS; Sun B; Guo M; Su C
    Onco Targets Ther; 2017; 10():5591-5604. PubMed ID: 29200874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA Differentiation Antagonizing Nonprotein Coding RNA Overexpression Accelerates Progression and Indicates Poor Prognosis in Pancreatic Ductal Adenocarcinoma [Retraction].
    Onco Targets Ther; 2023; 16():643-644. PubMed ID: 37525846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROS-Responsive Polymeric Micelles for Triggered Simultaneous Delivery of PLK1 Inhibitor/miR-34a and Effective Synergistic Therapy in Pancreatic Cancer.
    Xin X; Lin F; Wang Q; Yin L; Mahato RI
    ACS Appl Mater Interfaces; 2019 Apr; 11(16):14647-14659. PubMed ID: 30933478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA IUR upregulates miR-34a to inhibit pancreatic adenocarcinoma cell migratory and invasive abilities.
    Li R; Zhang J; Ma S; Zhao G; Li J; Li J; Wang X; Hui B
    Oncol Lett; 2021 Jul; 22(1):567. PubMed ID: 34113395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isovitexin Suppresses Cancer Stemness Property and Induces Apoptosis of Osteosarcoma Cells by Disruption of the DNMT1/miR-34a/Bcl-2 Axis [Retraction].
    Cancer Manag Res; 2023; 15():1003-1004. PubMed ID: 37706060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression and Clinical Significance of MYC-Associated Zinc Finger Protein in Pancreatic Carcinoma [Retraction].
    Onco Targets Ther; 2020; 13():8261. PubMed ID: 32904134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1 [Retraction].
    Onco Targets Ther; 2021; 14():4965-4966. PubMed ID: 34629880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma.
    Li CH; Xiao Z; Tong JH; To KF; Fang X; Cheng AS; Chen Y
    Int J Cancer; 2017 Jan; 140(1):120-129. PubMed ID: 27594424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal Tenascin-c Induces Proliferation and Invasion of Pancreatic Cancer Cells by WNT Signaling [Retraction].
    Onco Targets Ther; 2022; 15():1257-1258. PubMed ID: 36275183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 [Retraction].
    Onco Targets Ther; 2021; 14():123. PubMed ID: 33447053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-132 Can Inhibit Glioma Cells Invasion and Migration by Target MMP16 in vitro [Retraction].
    Onco Targets Ther; 2022; 15():215-216. PubMed ID: 35283634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-144 Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
    Onco Targets Ther; 2021; 14():3295-3296. PubMed ID: 34040393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction].
    Onco Targets Ther; 2021; 14():3597. PubMed ID: 34113125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-488 Inhibits Cell Growth and Metastasis in Renal Cell Carcinoma by Targeting HMGN5 [Retraction].
    Onco Targets Ther; 2021; 14():3351. PubMed ID: 34045871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-502-3P Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
    Onco Targets Ther; 2021; 14():3177. PubMed ID: 34040385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-125a Restrains Cell Migration and Invasion by Targeting STAT3 in Gastric Cancer Cells [Retraction].
    Onco Targets Ther; 2020; 13():6847. PubMed ID: 32764972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA DLEU1 Aggravates Glioma Progression via the miR-421/MEF2D Axis [Retraction].
    Onco Targets Ther; 2021; 14():4735-4736. PubMed ID: 34526776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1 [Retraction].
    Onco Targets Ther; 2022; 15():1407-1408. PubMed ID: 36444282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression [Retraction].
    Onco Targets Ther; 2022; 15():145-146. PubMed ID: 35173447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.